Literature DB >> 15011786

Technology evaluation: cT84.66, City of Hope.

Rosalyn D Blumenthal1.   

Abstract

Chimeric T84.66 (cT84.66) is a high affinity anti-carcinoembryonic antigen (CEA) immunoglobulin G1, that is being developed by City of Hope for the potential treatment of CEA-expressing malignancies.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15011786

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN： 1464-8431


  2 in total

1.  Nano-scale liquid chromatography/mass spectrometry and on-the-fly orthogonal array optimization for quantification of therapeutic monoclonal antibodies and the application in preclinical analysis.

Authors:  Xiaotao Duan; Lipeng Dai; Shang-Chiung Chen; Joseph P Balthasar; Jun Qu
Journal:  J Chromatogr A       Date:  2012-06-21       Impact factor: 4.759

Review 2.  Medical applications of leukocyte surface molecules--the CD molecules.

Authors:  Heddy Zola
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.